Auna SA (AUNA) Actualités

Auna Announces the Successful Redemption of Its 6.500% Senior Secured Notes Due 2025 With the Proceeds of Private Placement of Notes

Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Auna Announces 3Q24 Financial Results

Adjusted EBITDA increases 23% YoY FXN, maintaining strong growth Leverage ratio decreases 0.4x to 3.7x Auna (NYSE: AUNA) (“Auna” or the...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Auna Announces Reporting Dates for Third Quarter 2024 Financial Results

Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru...

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced...

Auna Announces 2Q24 Financial Results

Adjusted EBITDA increases 31% YoY, consolidating strong results OncoMexico launched in Monterrey Auna (NYSE: AUNA) (“Auna” or the “Company”), a...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]